Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology: Clinical Therapy and Diagnosis

18F-rhPSMA-7 positron emission tomography (PET) for the detection of biochemical recurrence of prostate cancer following curative-intent radiation therapy

Harun Ilhan, Markus Kroenke, Alexander Wurzer, Lena Ulbrich, Lena Jooß, Marcus Unterrainer, Peter Bartenstein, Saskia Kropf, Hans Wester, Wolfgang Weber and Matthias Eiber
Journal of Nuclear Medicine May 2019, 60 (supplement 1) 592;
Harun Ilhan
1Department of Nuclear Medicine Ludwig-Maximilian-University Munich Munich Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Markus Kroenke
4Department of Nuclear Medicine Technical University Munich Munich Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexander Wurzer
3Chair of Pharmaceutical Radiopharmacy Technical University Munich Garching Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lena Ulbrich
4Department of Nuclear Medicine Technical University Munich Munich Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lena Jooß
4Department of Nuclear Medicine Technical University Munich Munich Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marcus Unterrainer
1Department of Nuclear Medicine Ludwig-Maximilian-University Munich Munich Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Bartenstein
1Department of Nuclear Medicine Ludwig-Maximilian-University Munich Munich Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Saskia Kropf
2Scintomics GmbH Fuerstenfeldbruck Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hans Wester
3Chair of Pharmaceutical Radiopharmacy Technical University Munich Garching Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wolfgang Weber
4Department of Nuclear Medicine Technical University Munich Munich Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthias Eiber
4Department of Nuclear Medicine Technical University Munich Munich Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 60 no. supplement 1 592

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online May 21, 2019.

Copyright & Usage 
© 2019

Author Information

  1. Harun Ilhan1,
  2. Markus Kroenke4,
  3. Alexander Wurzer3,
  4. Lena Ulbrich4,
  5. Lena Jooß4,
  6. Marcus Unterrainer1,
  7. Peter Bartenstein1,
  8. Saskia Kropf2,
  9. Hans Wester3,
  10. Wolfgang Weber4 and
  11. Matthias Eiber4
  1. 1Department of Nuclear Medicine Ludwig-Maximilian-University Munich Munich Germany
  2. 2Scintomics GmbH Fuerstenfeldbruck Germany
  3. 3Chair of Pharmaceutical Radiopharmacy Technical University Munich Garching Germany
  4. 4Department of Nuclear Medicine Technical University Munich Munich Germany

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: May 2019 to April 2025

AbstractFullPdf
May 2019800
Jun 20198600
Jul 201910100
Aug 20193800
Sep 20191900
Oct 20191700
Nov 20193300
Dec 20192000
Jan 20202700
Feb 20201200
Mar 20203600
Apr 20201400
May 2020900
Jun 2020700
Jul 2020200
Aug 20202400
Sep 20203300
Oct 20201500
Nov 20202000
Dec 20201000
Jan 2021400
Feb 20211200
Mar 2021800
Apr 20211000
May 20211000
Jun 2021600
Jul 20211600
Aug 20213800
Sep 20211200
Oct 20211600
Nov 20218700
Dec 20214800
Jan 20227000
Feb 20222200
Mar 20221900
Apr 20221200
May 20223200
Jun 2022600
Jul 2022100
Aug 2022900
Sep 2022400
Oct 2022600
Nov 2022400
Dec 2022200
Jan 2023500
Feb 2023500
Mar 2023600
Apr 2023400
May 2023200
Jun 2023200
Jul 2023200
Aug 2023400
Sep 2023400
Oct 2023600
Nov 2023400
Dec 20231800
Jan 2024500
Feb 2024600
Mar 2024200
Apr 2024400
May 2024400
Jun 2024900
Aug 2024300
Sep 20241100
Oct 2024400
Nov 2024300
Dec 2024500
Feb 20251000
Mar 2025300
Apr 2025500
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 60, Issue supplement 1
May 1, 2019
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
18F-rhPSMA-7 positron emission tomography (PET) for the detection of biochemical recurrence of prostate cancer following curative-intent radiation therapy
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
18F-rhPSMA-7 positron emission tomography (PET) for the detection of biochemical recurrence of prostate cancer following curative-intent radiation therapy
Harun Ilhan, Markus Kroenke, Alexander Wurzer, Lena Ulbrich, Lena Jooß, Marcus Unterrainer, Peter Bartenstein, Saskia Kropf, Hans Wester, Wolfgang Weber, Matthias Eiber
Journal of Nuclear Medicine May 2019, 60 (supplement 1) 592;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
18F-rhPSMA-7 positron emission tomography (PET) for the detection of biochemical recurrence of prostate cancer following curative-intent radiation therapy
Harun Ilhan, Markus Kroenke, Alexander Wurzer, Lena Ulbrich, Lena Jooß, Marcus Unterrainer, Peter Bartenstein, Saskia Kropf, Hans Wester, Wolfgang Weber, Matthias Eiber
Journal of Nuclear Medicine May 2019, 60 (supplement 1) 592;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology: Clinical Therapy and Diagnosis

  • Added value of single photon emission computed tomography (SPECT) / Computed Tomography (CT) with radioiodine whole body scan in follow up of patients with differentiated thyroid cancer
  • Prognostic value of tumor metabolic imaging phenotype using FDG PET radiomics in HNSCC
  • The value of 18F-FDG PET / MR in skull-base bone invasion of nasopharyngeal carcinoma
Show more Oncology: Clinical Therapy and Diagnosis

Prostate Diagnosis I

  • The contribution of multiparametric pelvic and whole body MR to the interpretation of 18F-fluoromethylcholine (FCH) or 68Ga-HBED-CC PSMA-11 (PSMA) PET/CT in the detection of pelvic recurrence or distant metastases in patients with biochemical failure following radical prostatectomy.
  • PSMA-ligand PET/CT in patients with biochemical recurrent prostate cancer after radical prostatectomy: matched-pair comparison of 68Ga-PSMA-11 and 18F-PSMA-1007
  • Prospective evaluation of 68Ga-RM2 PET/MRI and 68Ga-PSMA11 PET/CT in patients with biochemical recurrence of prostate cancer
Show more Prostate Diagnosis I

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire